A

Alnylam Pharmaceuticals

Cambridge, United States Founded 2002 NASDAQ: ALNY

About

Leader in RNAi therapeutics using lipid nanoparticle delivery for genetic diseases

Company Details

Type
public
Employees
2400+
Funding
Public

Key Products

  • Onpattro
  • Givlaari
  • Oxlumo
Visit Website

Related Companies